Alex Mejia Garcia, MD
Primary Location
Scully-Welsh Cancer Center
Treatment & Services
- Autologous Hematopoietic Stem Cell Transplant
- Bone Marrow Transplant (BMT)
- Cancer Center
- CAR T-Cell Therapy
- Cellular Therapy
- Chemotherapy
- Hematopoietic Stem Cell Transplant
- Stem Cell Transplant
Specialty in Diseases & Conditions
- Amyloidosis
- Chronic Lymphocytic Leukemia
- Hairy Cell Leukemia
- Hematologic Malignancies
- HIV-related Lymphoma
- Hodgkin's Disease
- IgM Monoclonal Gammopathy
- Light Chain Deposition Disease
- Light Chain Proximal Tubulopathy
- Lymphoma
- Lymphoplasmacytic Lymphoma
- Myeloma
- Non-Hodgkin's Lymphoma
- Plasma Cell Leukemia (PCL)
- Plasmacytomas
- POEMS Syndrome (Polyneuropahty, Organomegaly, Endocrinopathy, M-Protein, Skin Manifestations)
- Rare Cancer and Blood Disease Program
- Swollen Lymph Nodes (Lymphadenopathy)
- Waldenstrom’s Macroglobulinemia
Insurance
Is Cleveland Clinic Florida Part of Your Insurance?
Review a list of accepted insurance plans for our Florida locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Alex Mejia Garcia, MD
Dr. Alex Mejia Garcia is a specialist who works at the Scully-Welsh Cancer Center located at Cleveland Clinic Indian River Hospital. He specializes in treating blood cancers such as chronic lymphocytic leukemia, lymphomas, and multiple myeloma. At Scully Welsh Cancer Center, he holds the position of Director of Hematology and Clinical Research.
Dr. Mejia Garcia completed his hematology-oncology fellowship at Thomas Jefferson University in Philadelphia before pursuing a fellowship in cancer drug development at UT Health San Antonio MD-Mays Anderson Cancer Center in San Antonio, Texas. He then directed the early-stage drug development program for blood cancers at that institution. Later, he joined the Department of Hematology & Medical Oncology at Cleveland Clinic-Taussig Cancer Institute in Cleveland, Ohio. His clinical and research focus has been on lymphomas and multiple myeloma.
Dr. Mejia Garcia has been the principal investigator in several national clinical trials and industry-sponsored trials for new lymphoma drugs. His research has been published in numerous peer-reviewed publications, including Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, the European Journal of Cancer, Cancer, and the Journal of Clinical Medicine Research.
Dr. Mejia Garcia follows a holistic, team-oriented, and patient-centered approach to cancer treatment. He takes into account not only the disease state, but also each person’s overall health, social support network, culture, and treatment goals. Dr. Mejia Garcia uses the latest cancer research to provide the best possible treatment options for each patient. He is passionate about making a positive impact on the lives of his patients and their families. Dr. Mejia Garcia focuses on helping patients understand their disease and treatment options while developing skills that will bring them greater success in their journey by reducing fear, anxiety, and stress.
Education & Professional Highlights
Appointed
2023
Education & Fellowships
Fellowship - University of Texas Health Science Center
Hematology/Oncology Drug Development
San Antonio,
TX USA
2015
Fellowship - Thomas Jefferson University Hospital
Hematology/Medical Oncology
Philadelphia,
PA USA
2013
Fellowship - Thomas Jefferson University Hospital
Clinical Pharmacology and Experimental Therapeutics
Philadelphia,
PA USA
2010
Residency - St. Vincent's Medical Center
Internal Medicine
Bridgeport,
CT USA
2007
Medical Education - Universidad Nacional Pedro Henriquez Urena Escuela De Medicina
Santo Domingo,
2001
Certifications
- Internal Medicine - Hematology
Research & Publications
See publications for Alex Mejia Garcia, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/28/2021, Dr. Mejia Garcia has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Consulting and/or Speaking. Dr. Mejia Garcia receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Celgene Corporation (a wholly-owned subsidiary of Bristol-Myers Squibb)
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
106 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
| Overall | Star Ratings | |
|---|---|---|
| Explains | 4.7 | |
| Courtesy, Respect & Concern | 4.8 | |
| Patient Rating of Doctor | 4.7 |
7 Patient Comments
© 2024 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on Mar 21, 2024
It was a pleasure to meet with Dr Garcia. He is very knowledgeable. It felt like talking to a friend.
Reviewed on Mar 18, 2024
Dr. Garcia was very thorough when explaining My diagnosis and helped me understand what I needed to be doing to continue on the bestPath for my health.He is extremely competent And has you leaving feeling he cares about you as a patient. I'm grateful that he is my doctor.
Reviewed on Jan 8, 2024
All good...Dr. Garcia has a sense of humor, which I like...I wish all doctors had a sense of humor...very pleasant visit.
Reviewed on Jan 2, 2024
The doctor- Dr. Garcia was absolutely terrific. He discussed the importance of tests and the future of my diagnosis, treatment.
Reviewed on Dec 5, 2023
Dr. Garcia was very caring. He consulted with my doctor in Michigan while I was in the office to make sure there was agreement on course of treatment.
Reviewed on Nov 7, 2023
Dr Garcia is very thorough and gives Understanable explanations.
Reviewed on Sep 25, 2023
Dr. Garcia replaced my doctor, Cintra, and he took time to familiarize himself with my case. He asked appropriate questions and really showed personal care!